October 3, 2025

New Monoclonal Antibody Program — Nordicus Forms NoviThera to Develop Psoriasis Therapy – Stock Titan

October 3, 2025

Stelara Biosimilar SYSA1902 Shows Clinical Equivalence for Plaque Psoriasis – Pharmacy Times

October 3, 2025

Phase 3 Trial Confirms SYSA1902 as Clinically Equivalent to Stelara for Moderate to Severe Plaque Psoriasis – geneonline.com

October 3, 2025

FDA approves Tremfya for pediatric plaque psoriasis, active psoriatic arthritis – Medical Xpress

October 3, 2025

Bridging the Treatment Gap in Pediatric Psoriasis and PsA With Guselkumab, With Vimal H. Prajapati, MD – HCPLive